Clinically 0 10 0 10 O
significant 11 22 11 22 O
cardiovascular 23 37 23 37 B-chronic_disease
disease 38 45 38 45 I-chronic_disease
, 45 46 45 46 O
including 47 56 47 56 O
myocardial 57 67 57 67 B-chronic_disease
infarct 68 75 68 75 I-chronic_disease
within 76 82 76 82 O
last 83 87 83 87 B-upper_bound
6 88 89 88 89 I-upper_bound
months 90 96 90 96 I-upper_bound
, 96 97 96 97 O
unstable 98 106 98 106 O
ischemic 107 115 107 115 B-chronic_disease
heart 116 121 116 121 I-chronic_disease
disease 122 129 122 129 I-chronic_disease
, 129 130 129 130 O
congestive 131 141 131 141 B-chronic_disease
heart 142 147 142 147 I-chronic_disease
failure 148 155 148 155 I-chronic_disease
, 155 156 155 156 O
or 157 159 157 159 O
angina 160 166 160 166 B-chronic_disease

Patients 0 8 167 175 O
being 9 14 176 181 O
treated 15 22 182 189 O
with 23 27 190 194 O
Natalizumab 28 39 195 206 B-treatment
, 39 40 206 207 O
Rituximab 41 50 208 217 B-treatment
, 50 51 217 218 O
and 52 55 219 222 O
Cyclophosphamide 56 72 223 239 B-treatment

Patients 0 8 240 248 O
having 9 15 249 255 O
received 16 24 256 264 O
oral 25 29 265 269 B-treatment
or 30 32 270 272 O
IV 33 35 273 275 B-treatment
corticosteroids 36 51 276 291 I-treatment
within 52 58 292 298 O
one 59 62 299 302 B-upper_bound
month 63 68 303 308 I-upper_bound
prior 69 74 309 314 I-upper_bound
to 75 77 315 317 O
initial 78 85 318 325 O
scan 86 90 326 330 O
demonstrating 91 104 331 344 O
contrast 105 113 345 353 O
enhancing 114 123 354 363 O
lesion 124 130 364 370 O

Patients 0 8 371 379 O
that 9 13 380 384 O
are 14 17 385 388 B-pregnancy
pregnant 18 26 389 397 I-pregnancy

Patients 0 8 398 406 O
unable 9 15 407 413 O
to 16 18 414 416 O
undergo 19 26 417 424 O
MRI 27 30 425 428 B-treatment
imaging 31 38 429 436 I-treatment
because 39 46 437 444 O
of 47 49 445 447 O
having 50 56 448 454 O
an 57 59 455 457 O
artificial 60 70 458 468 O
heart 71 76 469 474 O
valve 77 82 475 480 O
, 82 83 480 481 O
metal 84 89 482 487 O
plate 90 95 488 493 O
, 95 96 493 494 O
pin 97 100 495 498 O
, 100 101 498 499 O
or 102 104 500 502 O
other 105 110 503 508 O
metallic 111 119 509 517 O
objects 120 127 518 525 O
in 128 130 526 528 O
their 131 136 529 534 O
body 137 141 535 539 O
or 142 144 540 542 O
is 145 147 543 545 O
unable 148 154 546 552 O
to 155 157 553 555 O
complete 158 166 556 564 O
all 167 170 565 568 O
the 171 174 569 572 O
MRI 175 178 573 576 O
scans 179 184 577 582 O
required 185 193 583 591 O
for 194 197 592 595 O
this 198 202 596 600 O
study 203 208 601 606 O

Patients 0 8 607 615 O
unwilling 9 18 616 625 O
to 19 21 626 628 O
have 22 26 629 633 O
serial 27 33 634 640 O
MRI 34 37 641 644 B-treatment
exams 38 43 645 650 O

Patients 0 8 651 659 O
with 9 13 660 664 O
RRMS 14 18 665 669 B-chronic_disease
or 19 21 670 672 O
SPMS 22 26 673 677 B-chronic_disease
with 27 31 678 682 O
new 32 35 683 686 O
contrast 36 44 687 695 O
- 44 45 695 696 O
enhancing 45 54 696 705 O
lesions 55 62 706 713 O
who 63 66 714 717 O
will 67 71 718 722 O
start 72 77 723 728 O
as 78 80 729 731 O
part 81 85 732 736 O
of 86 88 737 739 O
their 89 94 740 745 O
standard 95 103 746 754 O
of 104 106 755 757 O
care 107 111 758 762 O
ACTH 112 116 763 767 O

Patients 0 8 768 776 O
with 9 13 777 781 O
a 14 15 782 783 O
known 16 21 784 789 O
history 22 29 790 797 O
of 30 32 798 800 O
diabetes 33 41 801 809 B-chronic_disease
mellitus 42 50 810 818 I-chronic_disease

Patients 0 8 819 827 O
with 9 13 828 832 O
a 14 15 833 834 O
known 16 21 835 840 O
history 22 29 841 848 O
of 30 32 849 851 O
osteoporosis 33 45 852 864 B-chronic_disease
or 46 48 865 867 O
bone 49 53 868 872 O
density 54 61 873 880 O
values 62 68 881 887 O
in 69 71 888 890 O
the 72 75 891 894 O
osteoporosis 76 88 895 907 O
range 89 94 908 913 O
at 95 97 914 916 O
screening 98 107 917 926 O

Patients 0 8 927 935 O
with 9 13 936 940 O
acute 14 19 941 946 B-chronic_disease
or 20 22 947 949 I-chronic_disease
chronic 23 30 950 957 I-chronic_disease
renal 31 36 958 963 I-chronic_disease
disease 37 44 964 971 I-chronic_disease
in 45 47 972 974 O
whom 48 52 975 979 O
administration 53 67 980 994 O
of 68 70 995 997 O
gadolinium 71 81 998 1008 O
may 82 85 1009 1012 O
pose 86 90 1013 1017 O
risk 91 95 1018 1022 O
of 96 98 1023 1025 O
nephrogenic 99 110 1026 1037 B-chronic_disease
systemic 111 119 1038 1046 I-chronic_disease
fibrosis 120 128 1047 1055 I-chronic_disease

Patients 0 8 1056 1064 O
with 9 13 1065 1069 O
known 14 19 1070 1075 O
or 20 22 1076 1078 O
new 23 26 1079 1082 O
allergy 27 34 1083 1090 O
to 35 37 1091 1093 O
ACTH 38 42 1094 1098 B-allergy_name

Premenopausal 0 13 1099 1112 O
woman 14 19 1113 1118 B-gender
not 20 23 1119 1122 O
willing 24 31 1123 1130 O
to 32 34 1131 1133 O
use 35 38 1134 1137 O
at 39 41 1138 1140 O
least 42 47 1141 1146 O
one 48 51 1147 1150 B-lower_bound
form 52 56 1151 1155 O
of 57 59 1156 1158 O
contraception 60 73 1159 1172 O

Progressive 0 11 1173 1184 O
neurological 12 24 1185 1197 B-chronic_disease
disorder 25 33 1198 1206 I-chronic_disease
other 34 39 1207 1212 O
than 40 44 1213 1217 O
RRMS 45 49 1218 1222 B-chronic_disease
or 50 52 1223 1225 O
SPMS 53 57 1226 1230 B-chronic_disease

Subject 0 7 1231 1238 O
currently 8 17 1239 1248 O
has 18 21 1249 1252 O
a 22 23 1253 1254 O
significant 24 35 1255 1266 O
medical 36 43 1267 1274 O
condition 44 53 1275 1284 O
( 54 55 1285 1286 O
other 55 60 1286 1291 O
than 61 65 1292 1296 O
MS 66 68 1297 1299 B-chronic_disease
) 68 69 1299 1300 O
including 70 79 1301 1310 O
the 80 83 1311 1314 O
following 84 93 1315 1324 O
: 93 94 1324 1325 O
neurological 95 107 1326 1338 B-chronic_disease
, 107 108 1338 1339 O
psychiatric 109 120 1340 1351 B-chronic_disease
, 120 121 1351 1352 O
metabolic 122 131 1353 1362 B-chronic_disease
, 131 132 1362 1363 O
hepatic 133 140 1364 1371 B-chronic_disease
, 140 141 1371 1372 O
renal 142 147 1373 1378 B-chronic_disease
, 147 148 1378 1379 O
hematological 149 162 1380 1393 B-chronic_disease
, 162 163 1393 1394 O
pulmonary 164 173 1395 1404 B-chronic_disease
, 173 174 1404 1405 O
cardiovascular 175 189 1406 1420 B-chronic_disease
( 190 191 1421 1422 O
including 191 200 1422 1431 O
uncontrolled 201 213 1432 1444 B-chronic_disease
hypertension 214 226 1445 1457 I-chronic_disease
) 226 227 1457 1458 O
, 227 228 1458 1459 O
gastrointestinal 229 245 1460 1476 B-chronic_disease
, 245 246 1476 1477 O
urological 247 257 1478 1488 B-chronic_disease
disorder 258 266 1489 1497 I-chronic_disease
, 266 267 1497 1498 O
or 268 270 1499 1501 O
central 271 278 1502 1509 O
nervous 279 286 1510 1517 O
system 287 293 1518 1524 O
( 294 295 1525 1526 O
CNS 295 298 1526 1529 O
) 298 299 1529 1530 O
infection 300 309 1531 1540 B-chronic_disease
that 310 314 1541 1545 O
would 315 320 1546 1551 O
pose 321 325 1552 1556 O
a 326 327 1557 1558 O
risk 328 332 1559 1563 O
to 333 335 1564 1566 O
the 336 339 1567 1570 O
subject 340 347 1571 1578 O
if 348 350 1579 1581 O
they 351 355 1582 1586 O
were 356 360 1587 1591 O
to 361 363 1592 1594 O
participate 364 375 1595 1606 O
in 376 378 1607 1609 O
the 379 382 1610 1613 O
study 383 388 1614 1619 O
or 389 391 1620 1622 O
that 392 396 1623 1627 O
might 397 402 1628 1633 O
confound 403 411 1634 1642 O
the 412 415 1643 1646 O
results 416 423 1647 1654 O
of 424 426 1655 1657 O
the 427 430 1658 1661 O
study 431 436 1662 1667 O

Subjects 0 8 1668 1676 O
on 9 11 1677 1679 O
chronic 12 19 1680 1687 B-treatment
steroid 20 27 1688 1695 I-treatment
therapy 28 35 1696 1703 I-treatment
for 36 39 1704 1707 O
treatment 40 49 1708 1717 B-treatment
of 50 52 1718 1720 O
MS 53 55 1721 1723 B-chronic_disease
or 56 58 1724 1726 O
other 59 64 1727 1732 O
systematic 65 75 1733 1743 B-chronic_disease
disease 76 83 1744 1751 I-chronic_disease

